Some patients may experience transient changes in blood pressure, though long-term cardiovascular outcomes studies have generally shown beneficial or neutral effects of GLP-1 receptor agonists on cardiovascular events
For both studies, we employed a randomized, between-subjects experiment in which participants were asked to evaluate a fictional target
But some chemical suppliers can offer more readily available compounds such as semaglutide sodium and semaglutide acetate
At a median follow-up of 3.4 years, the mean systolic blood pressure was 119.1 mmHg in the intensive treatment group, 134.8 mmHg in the standard treatment group
Between July 2023 - when Intuitive first mentioned weight loss drugs - and October 2023, medical device companies that were deemed GLP-1 losers sold off aggressively (e.g., diabetes medical devices, sleep apnea devices, bariatric surgery), while the GLP-1 companies themselves (Eli Lilly and Novo Nordisk) increased in value much more than the broader market
Stern Warning: Meddling with mitochondrial function is playing with the body's energy lifeline